Pages that link to "Q33272818"

The following pages link to Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays (Q33272818):

Displaying 44 items.

• Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5 (Q24316484) (← links)
• A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex (Q24318846) (← links)
• Analyzing the roles of multi-functional proteins in cells: The case of arrestins and GRKs (Q26785358) (← links)
• Phosphodiesterase-8A binds to and regulates Raf-1 kinase (Q28118406) (← links)
• RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5 (Q28386161) (← links)
• β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel (Q30448011) (← links)
• Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning (Q33564436) (← links)
• Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17beta-estradiol (Q33627286) (← links)
• β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation. (Q33776580) (← links)
• Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling (Q34205089) (← links)
• Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains (Q35535258) (← links)
• β-Adrenergic receptor stimulation increases surface NKCC2 expression in rat thick ascending limbs in a process inhibited by phosphodiesterase 4. (Q36455836) (← links)
• MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization (Q37160913) (← links)
• Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases. (Q37401396) (← links)
• Custom-designed proteins as novel therapeutic tools? The case of arrestins (Q37735949) (← links)
• Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? (Q37800215) (← links)
• Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions (Q37870035) (← links)
• Receptor tyrosine kinase–G-protein-coupled receptor signalling platforms: out of the shadow? (Q37879733) (← links)
• Small Molecule Allosteric Modulators of Phosphodiesterase 4 (Q37893064) (← links)
• Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system (Q37950792) (← links)
• PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease (Q37963175) (← links)
• Structural determinants of arrestin functions (Q38114211) (← links)
• Extensive shape shifting underlies functional versatility of arrestins (Q38200331) (← links)
• β-Adrenergic modulation of myocardial conduction velocity: Connexins vs. sodium current. (Q38277446) (← links)
• The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1. (Q38924866) (← links)
• Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners. (Q39085991) (← links)
• The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling (Q39381430) (← links)
• Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex (Q39492407) (← links)
• Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function (Q39528889) (← links)
• Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes (Q39589356) (← links)
• Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase (Q39855214) (← links)
• Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration (Q39970150) (← links)
• Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. (Q40087646) (← links)
• Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance. (Q41894869) (← links)
• Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains. (Q41981772) (← links)
• Cyclic AMP phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeability (Q42025999) (← links)
• The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3 (Q42077037) (← links)
• The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun. (Q42216011) (← links)
• Phosphodiesterase activity is regulated by CC2D1A that is implicated in non-syndromic intellectual disability (Q43101937) (← links)
• The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss (Q45068631) (← links)
• Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus (Q45074557) (← links)
• The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action (Q47732733) (← links)
• Identification of Integrin β1 as a Novel PAG1-Interacting Protein Involved in the Inherent Radioresistance of Human Laryngeal Carcinoma (Q90290581) (← links)
• Arrestins: Introducing Signaling Bias Into Multifunctional Proteins (Q93333139) (← links)